✦ LIBER ✦

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer: poor response rate in unselected patients

✍ Scribed by Hanna, CL; McKinna, FE; Williams, LB; Morrey, D; Adams, M; Mason, MD; Maughan, TS

Book ID: 109837165
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 437 KB
Volume: 72
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1995.409

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose folinic acid and 5-fluorouraci

High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer

✍ Yves H. Bécouarn; René C. Brunet; Marie-Laurence P. Rouhier; Emmanuel J. Bussièr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

High-dose chronomodulated infusion of 5-

High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients

✍ Edmondo Terzoli; Carlo Garufi; Albina Rita Zappalà; Barbara Vanni; Patrizia Pugl 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 217 KB

High-dose folinic acid with 5-fluorourac

High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma

✍ Highley, MS; Hill, ME; Ziras, N; Samandas, N; Mason, RC; Owen, W; Dussek, J; Bar 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

Continuous systemic 5-fluorouracil infus

Continuous systemic 5-fluorouracil infusion in advanced colorectal cancer: Results in 91 patients

✍ R. Hansen; E. Quebbeman; R. Ausman; J. Frick; P. Ritch; W. Schulte; C. Haas; P. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

Ninety-one patients with metastatic colorectal cancer were treated with continuous ambulatory 5-fluorouracil(5FU) infusion 250-300 mg/m2/day through a chronic indwelling central venous catheter. Twenty-six of the 91 patients (29%) had received previous bolus 5FU. Fifty-eight of the 91 patients (64%)

Bimonthly high dose leucovorin and 5-flu

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma

✍ Karine Beerblock; Yves Rinaldi; Thierry André; Christophe Louvet; Eric Raymond; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

with low dose LV. Based on these reports, a first-line Phase II study was performed in 101 patients with advanced colorectal carcinoma who were given a bimonthly

Randomized phase III Study of 5-fluorour

Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer

✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized